carsons7

BioDelivery Science: A Buy I Couldn't Refuse

Feuerstein's comments were appropriate, imho, as there are other alternate pain delivery methods as unique and effective as BDSI.

What is much more troubling to me is that BDSI has only $5 million of cash left, according to Yahoo Finance, finance.yahoo.com/q/ks...

It seems that a secondary stock offering is a must, in the not too distant future, which will of course dilute the existing shareholders..

Anyone else see it that way??

Ariad Pharmaceuticals: Significant Catalysts Approaching

The preclinical results on Ariad's compound '534 are absolutely stunning, any you will hear the details of the results in the fall oncology conferences..

Top 12 Indicators That the Economy Is Still Bad

Marc Courtney might be misleading investors by recommending BGS (B&G Foods), as it pays a $.68 dividend, and will only earn $.62 in 2009 and $.69 in 2010. When all the earnings of a company goes to pay the dividend, the results are usually a house of pain for the shareholders.

The Coming Economic Collapse, Part 1

With the huge crop of consuming baby boomers, forming families, and entering the their peak consuming years in the 1970's through 2000's, if it wasn't for the cheap China labor producing all the goods that we, the baby boomers, needed, the price of EVERYTHING would be up MUCH MORE than what it is today. That cheap China labor put a cap on what inflation would have been over this time period. Now with the marginal perpensity to save back in vouge, inflation of goods and services should stay in check, but debt inflation (read interest rates) will rise. Yes, Staginflation is back..

Bioterrorism: Anthrax and Biotech Companies

ADLS is the way to go as the investment idea from the group. A partnership with a big pharma company will be announced before the end of September this year, to market and file the NDA for the antibiotic Cethro....